Truist Securities reiterates Buy rating on argenx stock with $918 target
PositiveFinancial Markets

Truist Securities has reaffirmed its Buy rating on argenx stock, setting a target price of $918. This endorsement highlights the firm's confidence in argenx's potential for growth and success in the market, which is significant for investors looking for promising opportunities in biotech. A strong rating from a reputable firm can influence investor sentiment and drive stock performance.
— Curated by the World Pulse Now AI Editorial System